65
Participants
Start Date
April 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
C2L-OCT-01 PR, 30 mg
Administered by deep IM injection (gluteus) on days 1 and 42
Octreotide acetate prolonged release, 30 mg
Administered by deep IM (gluteus) on Days 1, 28 and 56
Republican Centre for Medical Rehabilitation and Water-therapy, Minsk
Semmelweis Egyetem Általános Orvostudományi, Budapest
"Institute of Endocrinology C. I. Parhon Bucharest", Bucharest
Institute of Endocrinology, University Clinical Center, Belgrade
Fakultná Nemocnica s Poliklinkou Bratislava, Bratislava
V.P. Komisarenko Institute of Endocrinology and Metabolism, AMS Ukraine, Kiev
Lead Sponsor
Ambrilia Biopharma, Inc.
INDUSTRY